Close Menu

NEW YORK (GenomeWeb) – California-based precision genomic medicine solutions provider Diagnomics announced late Friday that the Eone-Diagnomics Genome Center had a successful initial public offering on June 26. It is now listed on the Korea Securities Dealers Automated Quotation under the ticker EDGC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

The New York Times Magazine examines gender discrimination at the Salk Institute.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.